JPRN-UMIN000002977
Completed
Phase 4
Administration of Paroxetine Attenuates cognitive functon by using fMRI. - Administration of Paroxetine Attenuates cognitive functon by using fMRI.
Tamagawa University0 sites30 target enrollmentJanuary 5, 2010
Conditionsdepression
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- depression
- Sponsor
- Tamagawa University
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients with psychiatric disorder patients with hepatic, kidney, cardiac disorders patients taking other drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
The Effect of Atomoxetine on Cognitive Symptoms in Schizophrenia PatientsIRCT20211219053452N1Arak University of Medical Sciences40
Recruiting
Phase 3
The effect of Atomoxetine on Cognitive Function of Multiple SclerosisMultiple Sclerosis.Demyelinating disease of central nervous system, unspecifiedG37.9IRCT20210715051901N1Ahvaz University of Medical Sciences52
Suspended
Not Applicable
Effects of atomoxetine on cognitive functions in normal subjects using fMRIHealthy adultsJPRN-UMIN000012947ippon Medical School25
Completed
Phase 2
Effects of paroxetine and gabapentin on hot flashes in postmenopausal womeFlushing.FlushingIRCT201704143461N8Vice chancellor for research, Kermanshah University of Medical Sciences46
Completed
Not Applicable
THE EFFICACY OF PAROXETINE AND COGNITIVE-BEHAVIOURAL THERAPY IN THE TREATMENT OF LATE-LIFE PANIC DISORDER: A RANDOMIZED CONTROLLED TRIAL.NL-OMON231241. Radboud University Nijmegen, Behavioural Science Institute, Nijmegen, the Netherlands: Prof. dr. C.A.L. Hoogduin, Dr. G.P.J. Keijsers;<br>2. GGz Nijmegen, Outpatient Department for Anxiety Disorders, NijmegenPO Box 7049, 6503 GM Nijmegen, the Netherlands.80